FFH
CELG

Fairfax Financial Holdings’s Celgene Corp CELG Stock Holding History

Fairfax Financial Holdings’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-14,500
Closed -$1.37M – 37
2019
Q1 		$1.37M Buy
+14,500
New +$1.27M 0.06% 23

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Fairfax Financial Holdings's CELG Position: Q2 2019 in Review

Fairfax Financial Holdings sold out of Celgene Corp (CELG) in Q2 2019, closing a stake of 14,500 shares — an estimated $1.37M sold.

Fairfax Financial Holdings first reported a position in CELG in Q1 2019 and held it in 1 quarter. The position peaked at $1.37M in Q1 2019. 1,288 funds tracked by Wall St. Rank hold CELG as of Q2 2019.

  • Fairfax Financial Holdings reported no remaining Celgene Corp position as of Q2 2019 after selling out during the quarter.
  • Fairfax Financial Holdings sold 14,500 Celgene Corp shares in Q2 2019, an estimated $1.37M.
  • Fairfax Financial Holdings first reported a position in Celgene Corp in Q1 2019 and held it in 1 quarter.
  • Fairfax Financial Holdings's Celgene Corp position peaked at $1.37M in Q1 2019.
  • 1,288 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2019.

Based on Fairfax Financial Holdings's 13F filing for Q2 2019, filed 14 Aug 2019.